These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 24916780)

  • 1. Co-opting biology to deliver drugs.
    Yousefpour P; Chilkoti A
    Biotechnol Bioeng; 2014 Sep; 111(9):1699-716. PubMed ID: 24916780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting strategies using endogenous cells and proteins.
    Parayath NN; Amiji MM
    J Control Release; 2017 Jul; 258():81-94. PubMed ID: 28483514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal drug delivery system: patent reviews.
    Samad A; Ullah Z; Alam MI; Wais M; Shams MS
    Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):143-52. PubMed ID: 19519574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrohydrodynamic atomisation driven design and engineering of opportunistic particulate systems for applications in drug delivery, therapeutics and pharmaceutics.
    Ali A; Zaman A; Sayed E; Evans D; Morgan S; Samwell C; Hall J; Arshad MS; Singh N; Qutachi O; Chang MW; Ahmad Z
    Adv Drug Deliv Rev; 2021 Sep; 176():113788. PubMed ID: 33957180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug targeting by retrometabolic design: soft drugs and chemical delivery systems.
    Bodor N; Buchwald P
    J Recept Signal Transduct Res; 2001; 21(2-3):287-310. PubMed ID: 11757686
    [No Abstract]   [Full Text] [Related]  

  • 6. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
    Müllertz A; Ogbonna A; Ren S; Rades T
    J Pharm Pharmacol; 2010 Nov; 62(11):1622-36. PubMed ID: 21039546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current pharmaceutical design on adhesive based transdermal drug delivery systems.
    Ghosh A; Banerjee S; Kaity S; Wong TW
    Curr Pharm Des; 2015; 21(20):2771-83. PubMed ID: 25925119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patents on nanoparticulate drug delivery systems--a review.
    Bhavna ; Ali M; Baboota S; Ali J
    Recent Pat Drug Deliv Formul; 2008; 2(1):83-9. PubMed ID: 19075900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery systems improve pharmaceutical profile and facilitate medication adherence.
    Wertheimer AI; Santella TM; Finestone AJ; Levy RA
    Adv Ther; 2005; 22(6):559-77. PubMed ID: 16510373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future of the transdermal drug delivery market--have we barely touched the surface?
    Watkinson AC; Kearney MC; Quinn HL; Courtenay AJ; Donnelly RF
    Expert Opin Drug Deliv; 2016; 13(4):523-32. PubMed ID: 26646399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensing technologies and experimental platforms for the characterization of advanced oral drug delivery systems.
    Okeyo PO; Rajendran ST; Zór K; Boisen A
    Adv Drug Deliv Rev; 2021 Sep; 176():113850. PubMed ID: 34182015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs).
    Kankala RK; Xu PY; Chen BQ; Wang SB; Chen AZ
    Adv Drug Deliv Rev; 2021 Sep; 176():113846. PubMed ID: 34197896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte-based drug delivery.
    Rossi L; Serafini S; Pierigé F; Antonelli A; Cerasi A; Fraternale A; Chiarantini L; Magnani M
    Expert Opin Drug Deliv; 2005 Mar; 2(2):311-22. PubMed ID: 16296756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osmotically controlled drug delivery system with associated drugs.
    Gupta BP; Thakur N; Jain NP; Banweer J; Jain S
    J Pharm Pharm Sci; 2010; 13(4):571-88. PubMed ID: 21486532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into cellular uptake of nanoparticles.
    Kafshgari MH; Harding FJ; Voelcker NH
    Curr Drug Deliv; 2015; 12(1):63-77. PubMed ID: 25146441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrospun nanofibers in oral drug delivery.
    Ignatious F; Sun L; Lee CP; Baldoni J
    Pharm Res; 2010 Apr; 27(4):576-88. PubMed ID: 20143253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral osmotically driven systems: 30 years of development and clinical use.
    Malaterre V; Ogorka J; Loggia N; Gurny R
    Eur J Pharm Biopharm; 2009 Nov; 73(3):311-23. PubMed ID: 19602438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in drug delivery: potential and limitations of carbon nanotubes.
    Prakash S; Kulamarva AG
    Recent Pat Drug Deliv Formul; 2007; 1(3):214-21. PubMed ID: 19075888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome engineering in cell therapy and drug delivery.
    Sadeghi S; Tehrani FR; Tahmasebi S; Shafiee A; Hashemi SM
    Inflammopharmacology; 2023 Feb; 31(1):145-169. PubMed ID: 36609717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.